search
Back to results

Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP

Primary Purpose

Osteoarthritis

Status
Terminated
Phase
Phase 3
Locations
Netherlands
Study Type
Interventional
Intervention
PGET
PMMA
Sponsored by
Biomet Nederland BV
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring Hip prosthesis, Centralizer, Uncemented

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age between 18 and 75 years Diagnosis: Osteoarthritis Indicated for a primary hip prosthesis Exclusion Criteria: Previous hip surgery No informed consent Active infection in hip Immature skeleton Rheumatoid arthritis, M. Paget

Sites / Locations

  • Atrium medical centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

PGET

PMMA

Arm Description

Outcomes

Primary Outcome Measures

Alignment
Complications

Secondary Outcome Measures

Pain
Function

Full Information

First Posted
September 16, 2005
Last Updated
January 29, 2010
Sponsor
Biomet Nederland BV
Collaborators
Atrium Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00214760
Brief Title
Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP
Official Title
Phase 3 Randomised, Prospective Study Comparing the PMMA and the Resorbable PEGT/PBT Centralizer by the Uncemented BIHAPRO Total Hip Prosthesis
Study Type
Interventional

2. Study Status

Record Verification Date
November 2009
Overall Recruitment Status
Terminated
Why Stopped
On of the liners has been taken from the market
Study Start Date
May 2005 (undefined)
Primary Completion Date
August 2008 (Actual)
Study Completion Date
September 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Biomet Nederland BV
Collaborators
Atrium Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to analyse if the alignment of the stem and the number of complications of the new resorbable PEGT/PBT centralizer are comparable to the standard PMMA centralizer during the placement of an uncemented Bihapro hip prosthesis.
Detailed Description
For a correct placement and early fixation of an uncemented hip prosthesis, a centralizer is used. Normally, the centralizer is made of PMMA, the same material as bone cement. When a revision is needed, PMMA is difficult to remove, which is one of the reason not to use a cemented hip prosthesis. With a PMMA centralizer, still PMMA will remain in the bone and needs to be removed in case of a revision. PEGT/PBT is a reabsorbable material, which gives stability during the first month after the placement of the hip prosthesis. However, PEGT/PBT is reabsorped afterwards and, therefore, will not interfere with a revision procedure. The goal of this study is to analyse if the PEGT/PBT is as safe as PMMA in terms of alignment, direct postoperative complications and clinical results. Therefore, 100 patients indicated for a cementless Bihapro hip prosthesis which have signed an informed consent are included and randomised over the used centralizers using a weighted randomisation method. All patients will be treated equally. The patients are examined preoperatively, 1 day, 6 weeks, 3, 6, 12, 24 en 48 months postoperatively using an X-ray, the Harris hip score and a patient questionnaire, the Womac and SF36.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
Hip prosthesis, Centralizer, Uncemented

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PGET
Arm Type
Experimental
Arm Title
PMMA
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
PGET
Other Intervention Name(s)
resolbable liner
Intervention Description
resolbable liner
Intervention Type
Device
Intervention Name(s)
PMMA
Other Intervention Name(s)
cement liner
Intervention Description
cement liner
Primary Outcome Measure Information:
Title
Alignment
Time Frame
0,3,6,12,24 months
Title
Complications
Time Frame
all time points
Secondary Outcome Measure Information:
Title
Pain
Time Frame
0,3,6,12,24 months
Title
Function
Time Frame
0,3,6,12,24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age between 18 and 75 years Diagnosis: Osteoarthritis Indicated for a primary hip prosthesis Exclusion Criteria: Previous hip surgery No informed consent Active infection in hip Immature skeleton Rheumatoid arthritis, M. Paget
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joanne Bloemsaat-Minekus, PhD
Organizational Affiliation
Biomet Nederland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Atrium medical centre
City
Heerlen
ZIP/Postal Code
6401CX
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
10580823
Citation
Hernandez-Vaquero D, Murcia-Mazon A, Paz-Jimenez J, Alegre-Mateo R, Martinez-Garcia J, Pena-Vazquez J. Behavior of the femoral stem in the Bihapro hip prosthesis. Orthopedics. 1999 Nov;22(11):1049-53. doi: 10.3928/0147-7447-19991101-13.
Results Reference
result

Learn more about this trial

Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP

We'll reach out to this number within 24 hrs